DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/hhg4s5/hemoglobin_a1c) has announced the addition of the "Hemoglobin A1c ...
A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions, has been developed. Their innovative design leverages BRET -- bioluminescence ...
In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...
The global point of care testing market is projected to grow from USD 42 billion in 2025 to USD 64.8 billion by 2031, ...
This pilot study evaluates a newly developed point-of-care (PoC) device designed to measure bilirubin levels in human blood serum using a microfluidic cartridge and optoelectronic sensing module.
Correlation between the blue and green sensor channel outputs measured by the PoC device; (A) All the samples collected in this study; (B) Single patient highlighted by the yellow circle in (A). This ...
This blog was written by Simran Goyal, a fourth year medical student at the University of Cambridge. Simran was on placement for her Student Selected Component (SSC) with us between 10 December 2018 ...
In what represents its first patenting, San Diego-based Intrigue Health Inc. seeks protection for a diagnostic kit that its inventors say will bring clinical laboratory quality testing directly into ...
The global point of care testing market is projected to grow from USD 42 billion in 2025 to USD 64.8 billion by 2031, registering a CAGR of 7.5% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results